News Conference News ESC 2019 TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization L.A. McKeown September 09, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Conference News ESC 2012 PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease Yael L. Maxwell August 27, 2012
News Conference News CABG Favored for Triple Vessel Disease Regardless of Syntax Score August 29, 2011